Characterization of a novel venetoclax resistance mutation (BCL2 Phe104Ile) observed in follicular lymphoma

Br J Haematol. 2019 Sep;186(6):e188-e191. doi: 10.1111/bjh.16069. Epub 2019 Jun 24.
No abstract available

Keywords: BCL2; genetic analysis; lymphomas.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Substitution
  • Bridged Bicyclo Compounds, Heterocyclic / administration & dosage*
  • Drug Resistance, Neoplasm / genetics*
  • Humans
  • Lymphoma, Follicular / drug therapy
  • Lymphoma, Follicular / genetics*
  • Male
  • Middle Aged
  • Mutation, Missense*
  • Proto-Oncogene Proteins c-bcl-2 / genetics*
  • Sulfonamides / administration & dosage*

Substances

  • BCL2 protein, human
  • Bridged Bicyclo Compounds, Heterocyclic
  • Proto-Oncogene Proteins c-bcl-2
  • Sulfonamides
  • venetoclax